| Heading: |
Breast Cancer: Medical Treatments |
| Question ID: |
1789126 |
| UIN: |
HL6193 |
| House: |
Lords |
| Date tabled: |
2025-03-26 |
| Asking Member ID: |
4130 |
| Asking Member display name: |
Baroness Ritchie of Downpatrick
|
| Asking Member handle: |
MRitchieSD
|
| Asking Member Twitter reference: |
@MRitchieSD
|
| Member interest: |
false |
| Question text: |
To ask His Majesty's Government whether they plan to assess the impact of NICE’s severity modifier on people with secondary breast cancer. |
| Is named day: |
false |
| Date of holding answer: |
|
| Date answered: |
2025-04-02 |
| Date answer corrected: |
|
| Is holding answer: |
false |
| Is correcting answer: |
false |
| Answering Member ID: |
347 |
| Answering Member display name: |
Baroness Merron
|
| Answering Member handle: |
|
| Answering Member Twitter reference: |
Baroness Merron
|
| Correcting Member ID: |
|
| Correcting Member display name: |
|
| Correcting Member handle: |
|
| Correcting Member Twitter reference: |
|
| Answer text: |
The National Institute for Health and Care Excellence (NICE) is responsible for developing the methods and processes that it uses in its evaluations independently and in consultation with stakeholders. The severity modifier is based on evidence of societa... |
| Original answer text: |
|
| Comparable answer text: |
|
| Answering body ID: |
17 |
| Answering body name: |
Department of Health and Social Care |
| Tweeted: |
true |